Literature DB >> 32592004

Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

David K Lung1, Rebecca M Reese1, Elaine T Alarid2,3.   

Abstract

Transcriptional regulation of ESR1, the gene that encodes for estrogen receptor α (ER), is critical for regulating the downstream effects of the estrogen signaling pathway in breast cancer such as cell growth. ESR1 is a large and complex gene that is regulated by multiple regulatory elements, which has complicated our understanding of how ESR1 expression is controlled in the context of breast cancer. Early studies characterized the genomic structure of ESR1 with subsequent studies focused on identifying intrinsic (chromatin environment, transcription factors, signaling pathways) and extrinsic (tumor microenvironment, secreted factors) mechanisms that impact ESR1 gene expression. Currently, the introduction of genomic sequencing platforms and additional genome-wide technologies has provided additional insight on how chromatin structures may coordinate with these intrinsic and extrinsic mechanisms to regulate ESR1 expression. Understanding these interactions will allow us to have a clearer understanding of how ESR1 expression is regulated and eventually provide clues on how to influence its regulation with potential treatments. In this review, we highlight key studies concerning the genomic structure of ESR1, mechanisms that affect the dynamics of ESR1 expression, and considerations towards affecting ESR1 expression and hormone responsiveness in breast cancer.

Entities:  

Keywords:  Chromatin; Gene expression; Steroid receptor; Transcription

Year:  2020        PMID: 32592004      PMCID: PMC7384552          DOI: 10.1007/s12672-020-00388-0

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  202 in total

1.  Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer.

Authors:  Nathan R West; Leigh C Murphy; Peter H Watson
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

2.  Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.

Authors:  Hyun-Jin Kang; Min-Ho Lee; Hae-Lim Kang; Sung-Hye Kim; Jung-Ranh Ahn; Hyelin Na; Tae-Young Na; Yo Na Kim; Je Kyung Seong; Mi-Ock Lee
Journal:  Cancer Res       Date:  2014-01-10       Impact factor: 12.701

3.  Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes.

Authors:  Dipali Sharma; Neeraj K Saxena; Nancy E Davidson; Paula M Vertino
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

4.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

5.  Regulation of estrogen receptor-alpha gene expression by epidermal growth factor.

Authors:  A Stoica; M Saceda; V L Doraiswamy; C Coleman; M B Martin
Journal:  J Endocrinol       Date:  2000-05       Impact factor: 4.286

6.  Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.

Authors:  Lan Yan; Sharyl J Nass; Dawn Smith; William G Nelson; James G Herman; Nancy E Davidson
Journal:  Cancer Biol Ther       Date:  2003 Sep-Oct       Impact factor: 4.742

7.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

8.  Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.

Authors:  G L Powers; S J Ellison-Zelski; A J Casa; A V Lee; E T Alarid
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

9.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Authors:  Vasiliki Theodorou; Rory Stark; Suraj Menon; Jason S Carroll
Journal:  Genome Res       Date:  2012-11-21       Impact factor: 9.043

10.  Histone methyltransferases regulate the transcriptional expression of ERα and the proliferation of tamoxifen-resistant breast cancer cells.

Authors:  Seung-Su Kim; Min-Ho Lee; Mi-Ock Lee
Journal:  Breast Cancer Res Treat       Date:  2020-01-02       Impact factor: 4.872

View more
  7 in total

Review 1.  Skeletal muscle wasting: the estrogen side of sexual dimorphism.

Authors:  Shawna L McMillin; Everett C Minchew; Dawn A Lowe; Espen E Spangenburg
Journal:  Am J Physiol Cell Physiol       Date:  2021-11-17       Impact factor: 4.249

2.  TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin.

Authors:  Anna Maria Lena; Erica Foffi; Massimiliano Agostini; Mara Mancini; Margherita Annicchiarico-Petruzzelli; Daniel Aberdam; Tania Velletri; Yufang Shi; Gerry Melino; Ying Wang; Eleonora Candi
Journal:  Cell Cycle       Date:  2021-11-11       Impact factor: 4.534

3.  Short chain fatty acids exhibit selective estrogen receptor downregulator (SERD) activity in breast cancer.

Authors:  Abigail Schoeller; Keshav Karki; Arul Jayaraman; Robert S Chapkin; Stephen Safe
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

4.  DNA methylation and expression of estrogen receptor alpha in fathead minnows exposed to 17α-ethynylestradiol.

Authors:  J K Fetke; J W Martinson; R W Flick; W Huang; D C Bencic; M J See; E M Pilgrim; R W Debry; A D Biales
Journal:  Aquat Toxicol       Date:  2021-02-23       Impact factor: 4.964

Review 5.  Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease.

Authors:  Franck Mauvais-Jarvis; Carol A Lange; Ellis R Levin
Journal:  Endocr Rev       Date:  2022-07-13       Impact factor: 25.261

Review 6.  Estrogen receptor-α signaling in post-natal mammary development and breast cancers.

Authors:  Marine Adlanmérini; Elodie Chantalat; Mariam Rusidzé; I Raymond-Letron; Surya Cayre; Jean-François Arnal; Marie-Ange Deugnier; Françoise Lenfant
Journal:  Cell Mol Life Sci       Date:  2021-06-22       Impact factor: 9.261

Review 7.  Drug discovery oncology in a mouse: concepts, models and limitations.

Authors:  Jason E Long; Maja Jankovic; Danilo Maddalo
Journal:  Future Sci OA       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.